![Black Diamond Therapeutics Inc](/common/images/company/N_BDTX.png)
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its d... Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535. Show more
Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment...
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of...
Initial Phase 2 data of BDTX-1535 in 2L/3L EGFRm NSCLC patients on track for Q3 2024Enrollment ongoing in Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLC; initial data...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.49 | 9.02394106814 | 5.43 | 6.28 | 5.35 | 460531 | 5.90629196 | CS |
4 | 0.92 | 18.4 | 5 | 6.28 | 4.1501 | 555219 | 5.03598903 | CS |
12 | 0.76 | 14.7286821705 | 5.16 | 7.66 | 4.1501 | 715505 | 5.5241302 | CS |
26 | 3.19 | 116.84981685 | 2.73 | 7.66 | 2.605 | 658761 | 5.07035592 | CS |
52 | 1.05 | 21.5605749487 | 4.87 | 7.66 | 1.62 | 592974 | 4.09945031 | CS |
156 | -3.7 | -38.4615384615 | 9.62 | 10.5 | 1.18 | 681019 | 5.08121984 | CS |
260 | -27.08 | -82.0606060606 | 33 | 46.25 | 1.18 | 575670 | 9.15108721 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.